Microbial Biotechnology is a specialized branch of biotechnology that harnesses the power of microorganisms for various applications. It involves the genetic manipulation, cultivation, and utilization of microorganisms like bacteria, fungi, and viruses to develop products and processes beneficial to industries and society. Microbes play a pivotal role in producing biofuels, pharmaceuticals, and industrial enzymes, contributing to sustainable and eco-friendly solutions. Genetic engineering techniques enable the modification of microbial strains to enhance their capabilities, such as increased productivity or the ability to synthesize valuable compounds.
In the field of agriculture, microbial biotechnology is employed for developing biopesticides, biofertilizers, and promoting plant growth. Microbial processes are crucial in waste treatment and environmental management, aiding in the degradation of pollutants and the remediation of contaminated sites. The study of microbial communities, known as microbiomics, provides insights into various ecosystems and their functions. Continuous advancements in sequencing technologies and synthetic biology further expand the possibilities in microbial biotechnology, paving the way for novel applications and discoveries. The field also addresses ethical considerations, biosafety, and regulatory aspects associated with the use of genetically modified microorganisms.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia